Table 2.
In vivo and in vitro models relevant to GDM study.
Experimental Model | Species | Model Type | Experimental Features | References |
---|---|---|---|---|
Streptozotocin-Induced Diabetes Model. | Rat | In vivo | To study pathophysiology of GDM | Damasceno et al., 2014 [127] |
C57BL/6 | Mouse | In vivo | Pregestational DM defined by non-fasting BG > 13.3 mmol/L | Chang et al., 2005 [128] |
db/db | Mouse | In vivo | Obese, insulin resistant model with elevated glucose level; target gene is ObR gene. | Yamashita et al., 2001 [129] |
PrlR± | Mouse | In vivo | Target gene is PrlR gene. Decreased β-cells, decreased tolerance to glucose; repressed insulin secretion; impaired glucose homeostasis. | Nteeba et al., 2019 [130] |
HTR2b−/− | Mouse | In vivo | Target Gene is 5-HTR2b; decreased β-cell proliferation; high glucose intolerance. | Baeyens et al., 2016 [131] |
CD1 | Mouse | In vivo | Pregestational DM defined by non-fasting BG > 17.0 mmol/L | Ge et al., 2014 [132] |
Murine β-cell lines | Rat/Mouse | In vitro | Easy to culture; good option to test drugs and study cell physiology | Lilao-Garzón et al., 2021 [117] |
Human pancreatic islets | Human | In vitro | Maintain the islet structure and all cell types; used to study the biology of the human pancreas. | Lilao-Garzón et al., 2021 [117] |